VIRX: viracta.com Company Revenue

Corporate emblem and logo of Viracta Therapeutics, Inc. (VIRX)

The Viracta Therapeutics (VIRX) business model relies on outsourcing drug synthesis through CMOs; therefore, this chart on GURU.Markets contains the company's consolidated sales in accordance with strict compliance standards, and the 0.00 value shows the most recent figure. The development of drugs for viral tumors creates a unique niche. A patent monopoly on "killer genes" for treating EBV diseases ensures high margins for the biotech firm.

viracta.com (VIRX) Company Revenue: for the period 07/04/2022 - 02/16/2025

Comprehensive metric breakdowns and analytics for viracta.com (VIRX)

- market price and analyst price targets:
General company analysis:Viracta Therapeutics, Inc., VIRX
Core merchandise of Viracta Therapeutics

Viracta Therapeutics (VIRX) is focusing on obtaining approval for its lymphoma drug and securing commercial partners, making current cash flows critical. Analyzing the company's sales metrics allows for the tracking of daily inflows, identifying cooling demand or a fundamental weakening of the business. Monitoring this metric helps conduct timely stress testing and avoid purchasing the asset at its peak, thereby minimizing the risk of capital drawdown.

Key competitors

Company Revenue ONC|Revenue and Sales Volume HALO|RVMD (Revolution Medicines, Inc.) - Company Sales Revenue|Company Revenue Ascentage Pharma Corp AAPG|Company Total Sales Volume CG Oncology, Inc.|URGN - Company Revenue|Bicara Therapeutics Inc. (BCAX) - Company Sales|Personalis Inc (PSNL) - Company Revenue|ERAS - Company Gross Revenue|DCTH (Delcath Systems Inc) - Revenue and Sales Volume|Company Revenue YMAB|Revenue and Sales Volume AURA|Company Revenue CADL (Candel)|Accuray, Inc. - Company Sales|SELLAS Life Sciences Group Inc. - Company Revenue|ACTU: Company Sales|Company Total Revenue Citius Oncology Inc|HURA: Revenue and Sales Volume|TARA: Company Total Sales|FATE (fatetherapeutics.com) - Revenue and Sales Volume|Company Sales Aadi Bioscience Inc (WHWK)|Revenue and Sales Volume TCRX|CSBR - Company Total Revenue|Revenue and Sales Volume XBIT (XBiotech Inc.)|CEL-SCI Corporation (CVM) - Company Total Revenue|OSTX: Company Sales|Company Sales Revenue RADX (Radiopharm Theranostics)|Artiva (ARTV) - Company Revenue|ANL: Company Total Sales|VERU (Veru Corporation) - Revenue and Sales Volume|Company Total Revenue Tempest Therapeutics, Inc. TPST|Revenue and Sales Volume XLO|Renovaro - Company Sales Volume|Company Revenue Mural Bio MURA|KAPA: Company Sales Volume|OnKure Therapeutics - Revenue and Sales Volume|Company Gross Revenue w2.cytomed.sg GDTC|CRIS: Revenue and Sales Volume|Company Sales Apollomics Inc.|THAR (Tharimmune Corporation) - Revenue and Sales Volume|Revenue and Sales Volume Advanced Biomed Inc|Revenue and Sales Volume GNPX|Company Sales Calidi Biotherapeutics Inc. CLDI|Company Revenue Sunshine Biopharma Inc. SBFM|Company Gross Revenue Xenetic Biosciences (XBIO)|SLRX - Company Revenue|Company Total Revenue Kitov Pharma|AON (AONC) - Company Revenue|Company Sales BeiGene|Company Revenue checkpointtx.com|Company Sales Volume ELEV (Elevation Oncology)|Revenue and Sales Volume ICAD|Ikena Oncology - Company Sales Volume|Company Revenue Notable Labs, Ltd. NTBL|morphosys.com (MOR) - Company Total Revenue|NAYA Biosciences Inc - Revenue and Sales Volume|AAPGV: Company Revenue